UBE2Q2 promotes tumor progression and glycolysis of hepatocellular carcinoma through NF-κB/HIF1α signal pathway
Cellular Oncology · 2025-06 · 48 (3) · 637-654
DOI: 10.1007/s13402-025-01037-w ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular Oncology, online erschienen am 20.01.2025. Verfasst von Xiaoling Wu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary and Pancreatic Surgery, Zhongnan Hospital of Wuhan University, 169 Donghu Road, Wuhan, Hubei, 430071, PR China. Hauptthemen laut MEDLINE: Signal Transduction, Carcinoma, Hepatocellular, Liver Neoplasms, Cytoskeletal Proteins. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Research Fund of the Health Commission of Hubei Province, Cancer research and translational platform project of Zhongnan Hospital of Wuhan University, Translational medicine and interdisciplinary research joint fund project of Zhongnan Hospital of Wuhan University.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hepatobiliary and Pancreatic Surgery, Zhongnan Hospital of Wuhan University, 169 Donghu Road, Wuhan, Hubei, 430071, PR China.
- Department of Liver Surgery, Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Zhongshan Hospital, Liver Cancer Institute, Fudan University, Shanghai, China.
- Research Unit of Liver Cancer Recurrence and Metastasis, Chinese Academy of Medical Sciences, Beijing, China.
- Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Shanghai, China.
- Clinical Medicine Research Center for Minimally Invasive Procedure of Hepatobiliary & Pancreatic Diseases of Hubei Province, Wuhan, Hubei, 430071, PR China.
- Department of Hepatobiliary and Pancreatic Surgery, Zhongnan Hospital of Wuhan University, 169 Donghu Road, Wuhan, Hubei, 430071, PR China. chenxi2022@whu.edu.cn.
Förderung
- Research Fund of the Health Commission of Hubei Province
- Cancer research and translational platform project of Zhongnan Hospital of Wuhan University
- Translational medicine and interdisciplinary research joint fund project of Zhongnan Hospital of Wuhan University
Zitieren
APA
Wu, X., Chen, Y., He, W., Yao, Y., Liu, Y., Xia, P., Zhang, H., Li, X., Guo, Y., Chen, X., Ma, W., & Yuan, Y. (2025). UBE2Q2 promotes tumor progression and glycolysis of hepatocellular carcinoma through NF-κB/HIF1α signal pathway. Cellular Oncology, 48(3), 637-654. https://doi.org/10.1007/s13402-025-01037-w
Vancouver
Wu X, Chen Y, He W, Yao Y, Liu Y, Xia P, et al. UBE2Q2 promotes tumor progression and glycolysis of hepatocellular carcinoma through NF-κB/HIF1α signal pathway. Cellular Oncology. 2025;48(3):637-654. doi:10.1007/s13402-025-01037-w
BibTeX
@article{Wu2025,
author = {Wu, Xiaoling and Chen, Yiran and He, Wenzhi and Yao, Ye and Liu, Yingyi and Xia, Peng and Zhang, Hao and Li, Xiaomian and Guo, Yonghua and Chen, Xi and Ma, Weijie and Yuan, Yufeng},
title = {UBE2Q2 promotes tumor progression and glycolysis of hepatocellular carcinoma through NF-κB/HIF1α signal pathway},
journal = {Cellular Oncology},
year = {2025},
volume = {48},
number = {3},
pages = {637--654},
doi = {10.1007/s13402-025-01037-w}
}
EUVIMED